Publications by authors named "Daniela Abriss"

Claim this Profile
G
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells.
Jing Zeng, My Anh Nguyen, Pengpeng Liu, Lucas Ferreira da Silva, Sébastien Levesque, Daniela Abriss

Cell Stem Cell· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene editing without culture evades genotoxicity in human hematopoietic stem cells.
Jing Zeng, My Anh Nguyen, Pengpeng Liu, Lucas Ferreira da Silva, Linda Y Lin, Daniela Abriss

bioRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transcriptional Genetic Silencing of to Treat Sickle Cell Disease.
Erica B Esrick, Leslie E Lehmann, Alessandra Biffi, Maureen Achebe, Christian Brendel, Daniela Abriss

N Engl J Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy.
Christian Brendel, Olivier Negre, Michael Rothe, Swaroopa Guda, Geoff Parsons, Daniela Abriss

Mol Ther Methods Clin Dev· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
Christian Brendel, Michael Rothe, Giorgia Santilli, Sabine Charrier, Stefan Stein, Daniela Abriss

Hum Gene Ther Clin Dev· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells.
Christian Brendel, Benjamin Goebel, Abriss Daniela, Martijn Brugman, Sabrina Kneissl

Mol Ther· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A.
Stefanie D Roth, Jörg Schüttrumpf, Peter Milanov, Daniela Abriss, Christopher Ungerer

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
Peter Milanov, Lacramioara Ivanciu, Daniela Abriss, Patricia Quade-Lyssy, Wolfgang Miesbach

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.
Jörg Schüttrumpf, Peter Milanov, Daniela Abriss, Stefanie Roth, Torsten Tonn

Hum Gene Ther· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor VIII-eGFP fusion proteins with preserved functional activity for the analysis of the early secretory pathway of factor VIII.
Stefan Heinz, Jörg Schüttrumpf, Jeremy C Simpson, Rainer Pepperkok, Gerry A Nicolaes, Daniela Abriss

Thromb Haemost· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen-induced changes in hemoglobin expression in Drosophila.
Eva Gleixner, Daniela Abriss, Boris Adryan, Melanie Kraemer, Frank Gerlach

FEBS J· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis